// App-Quantinova.ai

POS28 : Three-year transfemoral outcomes of the European pivotal trial for second generation balloon-expandable transcatheter heart valves

Researchers

Presenter

  • Sack S

Principal Investigators

  • N/A

Medical Centers

  • Academic General Hospital Munich - Hospital Schwabing, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Chronic obstructive pulmonary disease

  • Paravalvular regurgitation

  • Congestive heart failure

  • Coronary Artery Disease

  • Myocardial infarction

  • Renal insufficiency

  • Hypertension

  • Infective endocarditis

  • Venous thrombosis

  • Solid malignancies

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • observational

  • single arm

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved